Immunovant, Inc. IMVT Balance Sheet Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| $902.11M+26.4% | $713.97M+12.4% | $635.37M+68.7% | $376.53M-23.8% | ||
| $6.68M-22.3% | $8.6M-0.1% | $8.61M-53.1% | $18.36M-8.9% | ||
| $948.82M+23.6% | $767.66M+15.3% | $665.77M+64.7% | $404.33M-21.2% | ||
| $443K-47.5% | $844K+82.7% | $462K+38.7% | $333K+0.9% | ||
| $957.01M+23.3% | $776.22M+16.5% | $666.37M+64.2% | $405.84M-21.3% | ||
| $7.54M-57.3% | $17.66M+147% | $7.16M+429% | $1.35M-92.7% | ||
| $104.42M+51.8% | $68.78M+41.5% | $48.61M+12.3% | $43.3M-2.7% | ||
| $104.42M+51.8% | $68.78M+41.5% | $48.61M+12.1% | $43.34M-5.2% | ||
| $20K+25.0% | $16K+14.3% | $14K+7.7% | $13K+8.3% | ||
| -$1.75B-40.8% | -$1.24B-50.1% | -$825.68M-45.8% | -$566.35M-59.4% | ||
| $852.59M+20.5% | $707.45M+14.5% | $617.76M+70.4% | $362.49M-22.8% | ||
| $957.01M+23.3% | $776.22M+16.5% | $666.37M+64.2% | $405.84M-21.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Immunovant, Inc.'s total assets?
- Immunovant, Inc. (IMVT) holds $957.0M in total assets, up 23.3% year over year.
- How much debt does Immunovant, Inc. have?
- Immunovant, Inc. carries $72.0K in total debt against $852.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Immunovant, Inc. have?
- Immunovant, Inc. holds $902.1M in cash and equivalents.
- Can Immunovant, Inc. cover its short-term obligations?
- Its current ratio is 9.09 — current assets exceed current liabilities.
- Where does Immunovant, Inc.'s balance sheet data come from?
- Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.